Cargando…

Hypoxia-targeted (131)I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery

Adoptively transferred mesenchymal stem cells (MSCs) home to solid tumors. Biologic features within the tumor environment can be used to selectively activate transgenes in engineered MSCs after tumor invasion. One of the characteristic features of solid tumors is hypoxia. We evaluated a hypoxia-base...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller, Andrea M., Schmohl, Kathrin A., Knoop, Kerstin, Schug, Christina, Urnauer, Sarah, Hagenhoff, Anna, Clevert, Dirk-André, Ingrisch, Michael, Niess, Hanno, Carlsen, Janette, Zach, Christian, Wagner, Ernst, Bartenstein, Peter, Nelson, Peter J., Spitzweg, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342382/ https://www.ncbi.nlm.nih.gov/pubmed/27458162 http://dx.doi.org/10.18632/oncotarget.10758

Ejemplares similares

The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy
por: Kitzberger, Carolin, et al.
Publicado: (2022)

Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (NIS) gene expression using a heat-inducible gene promoter in engineered mesenchymal stem cells
por: Tutter, Mariella, et al.
Publicado: (2020)

EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases
por: Urnauer, Sarah, et al.
Publicado: (2017)

Selective sodium iodide symporter (NIS) genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexes
por: Spellerberg, Rebekka, et al.
Publicado: (2021)

Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene
por: Schmohl, Kathrin A., et al.
Publicado: (2017)

Taking Advantage of the TGFB1 Biology in Differentiated Thyroid Cancer to Stimulate Sodium Iodide Symporter (NIS)-Mediated Iodide Uptake in Engineered Mesenchymal Stem Cells
por: Han, Yang, et al.
Publicado: (2021)

Dimerization of the Sodium/Iodide Symporter
por: Thompson, Rebecca J., et al.
Publicado: (2019)

SUN-339 External Beam Radiation Therapy Improves TGFB1-Induced Mesenchymal Stem Cell-Mediated NIS Gene (131)I Therapy
por: Schug, Christina, et al.
Publicado: (2019)

Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma
por: Spellerberg, Rebekka, et al.
Publicado: (2022)

I-131 false-positive uptake in a thymic cyst with expression of the sodium-iodide symporter: A case report
por: Yano, Erina, et al.
Publicado: (2022)

OR14-05 Taking Advantage Of The Interleukin-6-Biology In Differentiated Thyroid Cancer To Stimulate Sodium Iodide Symporter (NIS)-mediated Iodide Uptake In Engineered Mesenchymal Stem Cells
por: Florentine Koehler, Viktoria, et al.
Publicado: (2023)

Anti-EpCAM Functionalized I-131 Radiolabeled Biomimetic Nanocarrier Sodium/Iodide-Symporter-Mediated Breast-Cancer Treatment
por: Marshall, Suphalak Khamruang, et al.
Publicado: (2022)

Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice
por: Kitzberger, Carolin, et al.
Publicado: (2023)

Sodium iodide symporter-targeted gene therapy in glioblastoma
por: Nicola, Juan Pablo, et al.
Publicado: (2023)

Tumor microenvironment affects exogenous sodium/iodide symporter expression
por: Castillo-Rivera, Fabio, et al.
Publicado: (2020)

In vivo Molecular Imaging and Radionuclide ((131)I) Therapy of Human Nasopharyngeal Carcinoma Cells Transfected with a Lentivirus Expressing Sodium Iodide Symporter
por: Shi, Shuo, et al.
Publicado: (2015)

Decreased Expression of Thyroglobulin and Sodium Iodide Symporter Genes in Hashimoto's Thyroiditis
por: Popławska-Kita, Anna, et al.
Publicado: (2014)

Physiological sodium concentrations enhance the iodide affinity of the Na(+)/I(−) symporter
por: Nicola, Juan P., et al.
Publicado: (2014)

Conserved charged amino acid residues in the extracellular region of sodium/iodide symporter are critical for iodide transport activity
por: Li, Chia-Cheng, et al.
Publicado: (2010)

Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer
por: Micali, Salvatore, et al.
Publicado: (2014)

In Vivo Myoblasts Tracking Using the Sodium Iodide Symporter Gene Expression in Dogs
por: Punzón, Isabel, et al.
Publicado: (2020)

Targeting non-canonical pathways as a strategy to modulate the sodium iodide symporter
por: Read, Martin L., et al.
Publicado: (2022)

SUN-120 Regional Hyperthermia Enhances Selective Mesenchymal Stem Cell Migration Towards the Tumor Stroma
por: Tutter, Mariella, et al.
Publicado: (2020)

The Sodium Iodide Symporter (NIS) as an Imaging Reporter for Gene, Viral, and Cell-based Therapies
por: Penheiter, Alan R, et al.
Publicado: (2012)

Resveratrol Inhibits Sodium/Iodide Symporter Gene Expression and Function in Rat Thyroid Cells
por: Giuliani, Cesidio, et al.
Publicado: (2014)

Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake
por: Chung, Taemoon, et al.
Publicado: (2015)

Sodium Iodide Symporter PET and BLI Noninvasively Reveal Mesoangioblast Survival in Dystrophic Mice
por: Holvoet, Bryan, et al.
Publicado: (2015)

Mechanisms of Sodium/Iodide Symporter-Mediated Mammary Gland Iodine Compensation during Lactation
por: Fu, Min, et al.
Publicado: (2022)

Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter
por: Huang, R, et al.
Publicado: (2011)

The Sodium Iodide Symporter (NIS) and Potential Regulators in Normal, Benign and Malignant Human Breast Tissue
por: Ryan, James, et al.
Publicado: (2011)

Sodium Iodide Symporter for Nuclear Molecular Imaging and Gene Therapy: From Bedside to Bench and Back
por: Ahn, Byeong-Cheol
Publicado: (2012)

Induction of Sodium/Iodide Symporter (NIS) Expression and Radioiodine Uptake in Non-Thyroid Cancer Cells
por: Liu, Zhi, et al.
Publicado: (2012)

Effect of thyroid statuses on sodium/iodide symporter (NIS) gene expression in the extrathyroidal tissues in mice
por: Harun-Or-Rashid, et al.
Publicado: (2010)

[(18)F]tetrafluoroborate as a PET tracer for the sodium/iodide symporter: the importance of specific activity
por: Khoshnevisan, Alex, et al.
Publicado: (2016)

Selumetinib Activity in Thyroid Cancer Cells: Modulation of Sodium Iodide Symporter and Associated miRNAs
por: Wächter, Sabine, et al.
Publicado: (2018)

Pro-tumorigenic non-pump function of sodium iodide symporter: A reimagined Trojan horse?
por: Feng, Fang, et al.
Publicado: (2019)

Prognostic Significance of Sodium Iodide Symporter and Deiodinase Enzymes mRNA Expression in Gastric Cancer
por: Mishra, Alok, et al.
Publicado: (2020)

Extracellular vesicles deliver sodium iodide symporter protein and promote cancer cell radioiodine therapy
por: Lee, Jin Hee, et al.
Publicado: (2022)

Basolateral Sorting of the Sodium/Iodide Symporter Is Mediated by Adaptor Protein 1 Clathrin Adaptor Complexes
por: Koumarianou, Petrina, et al.
Publicado: (2022)

High molar activity [(18)F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET
por: Soloviev, Dmitry, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_idbsfee0kikgff2jhj96jin39q